DNA hypermethylation status of multiple genes in soft tissue sarcomas

Modern Pathology

Volumn 19, Issue 1, 2006, Pages 106-114

  Kawaguchi, Ken Ichi ^a   Oda, Yoshinao ^a,b   Saito, Tsuyoshi ^a   Yamamoto, Hidetaka ^a   Takahira, Tomonari ^a   Kobayashi, Chikashi ^a   Tamiya, Sadafumi ^a   Tateishi, Naomi ^a   Iwamoto, Yukihide ^b   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Methylation specific PCR; Promoter hypermethylation; Soft tissue sarcoma; Tumor related genes

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; GLUTATHIONE TRANSFERASE P1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN MLH1; PROTEIN P16; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADULT; AGED; ARTICLE; CANCER STAGING; DNA METHYLATION; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NERVE SHEATH TUMOR; PATHOGENESIS; PERIPHERAL NERVE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SOFT TISSUE SARCOMA; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PTEN PHOSPHOHYDROLASE; RETINOBLASTOMA PROTEIN; SARCOMA; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 32844460417     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800502     Document Type: Article

References (35)

1. El-Rifai W, Sarlomo-Rikala M, Knuutila S, et al. DNA copy number change in development and progression in leiomyosarcoma of soft tissues. Am J Pathol 1998;153:985-990.
2. Plaat BE, Molenaar WM, Mastik MF, et al. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs neurofibromatosis-type-1-associated malignant schwannomas. Int J Cancer 1999;83:171-178.
3. Chibon F, Mairal A, Freneaux P, et al. The RB1 gene is the target of chromosome 13 deletions in malignant fibrous histiocytoma. Cancer Res 2000;60:6339-6345.
4. Derre J, Lagace R, Nicolas A, et al. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest 2001;81:211-215.
5. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998;72:141-146.
6. Costello JF, Fruhwald MC, Smiraglia DJ, et al. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns. Nat Genet 2000;24:132-138.
7. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-3229.
8. Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor-suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995;55:4531-4535.
9. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-4530.
10. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-692.
11. Benassi MS, Molendini L, Gamberi G, et al. Alteration of pRB/p16/cdk4 regulation in human osteosarcoma. Int J Cancer 1999;84:489-493.
12. Orlow I, Drobnjak M, Zhang Z, et al. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: Effect on survival. J Natl Cancer Inst 1999;91:73-79.
13. Wei G, Lonardo F, Ueda T, et al. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Int J Cancer 1999;80:199-204.
14. Benassi MS, Molendini L, Gamberi G, et al. Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma. Cancer 2001;15:3062-3067.
15. Lopez-Guerrero JA, Pellin A, Noguera R, et al. Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest 2001;81:803-814.
16. Harada K, Toyooka S, Maitra A, et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 2002;21:4345-4349.
17. Kawaguchi K, Oda Y, Saito T, et al. Mechanisms of inactivation of p16 gene in leiomyosarcoma of soft tissue: A decrease expression of p16 expression correlates with poor prognosis and the methylation status. J Pathol 2003;201:487-495.
18. Seidel C, Bartel F, Rastetter M, et al. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma. Int J Cancer 2005;104:442-447.
19. Fleming ID, Cooper JS, Henson DE. Soft tissue sarcoma. In: American Joint Committee on Cancer (eds). Cancer Staging Manual, 5th edn. Lippincott-Raven: Philadelphia, PA, 1998, pp 149-156.
20. Lo KW, Kwong J, Hui ABY, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001;61:3877-3881.
21. Simpson DJ, Clayton R, Farrell WE. Preferential loss of death associated protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion. Oncogene 2002;21:1217-1224.
22. Esteller M, Corn PG, Urena JM, et al. Inactivation of glutathione S-transferase Pl gene by promoter hypermethylation in human neoplasia. Cancer Res 1998;58:4515-4518.
23. Soria JC, Lee HY, Lee JI, et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 2002;8:1178-1184.
24. Fleisher AS, Esteller M, Wang S, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999;59:1090-1095.
25. Kang GH, Shim YH, Ro JY. Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinoma with replication error. Lab Invest 1999;79:903-909.
26. Esteller M, Tortola S, Toyota M, et al. Hypermethylation-associated inactivation of p14ARF is independent of p16INK4a methylation and p53 mutational status. Cancer Res 2000;60:129-133.
27. Simpson DJ, Hibberts NA, McNicol AM, et al. Loss of pRb expression in pituitary adenomas is associated with methylation of RB1 CpG island. Cancer Res 2000;60:1211-1216.
28. Matsukura S, Miyazaki K, Yakushiji H, et al. Combined loss of expression of O6-methylguanine-DNA methyl-transferase and hMLH1 accelerates progression of hepatocellular carcinoma. J Surg Oncol 2003;82:194-200.
29. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-167.
30. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168-174.
31. Pegg AE. Mammalian O6-alkylguanine-DNA alkyl-transferase regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 1990;50:6119-6129.
32. Day III RS, Ziolkowski CH, Scudiero DA, et al. Defective repair of alkylated DNA by human tumor and SV40-transformed human cell strains. Nature (London) 1980;288:724-727.
33. Fornace Jr AJ, Papathanasiou MA, Hollander MC, et al. Expression of the O6-methylguanine DNA methyl-transferase gene MGMT in MER+ and MER- human tumor cells. Cancer Res 1990;50:7908-7911.
34. Esteller M, Hamilton SR, Burger PC, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-797.
35. Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of tie DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000;60:2368-2371.